ZBIO
Valuation Ratios
| Breakdown | 2024-12-31 |
|---|---|
| Price to Earnings | -0.69 |
| Price to Sales | 21.62 |
| Book Value Per Common Share | 7.48 |
| Price to Book | 1.10 |
| Price to Operating Cash Flow | -0.90 |
| Price to Free Cash Flow | |
| Enterprise Value to EBITDA |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Price to Earnings | -6.79 | -4.73 | -9.88 | -0.59 | |
| Price to Sales | 93.12 | 40.54 | 33.03 | ||
| Book Value Per Common Share | 4.65 | 5.69 | 6.80 | 7.48 | 8.60 |
| Price to Book | 4.77 | 1.70 | 1.16 | 1.10 | 1.97 |
| Price to Operating Cash Flow | -7.76 | -5.14 | -8.91 | -0.76 | |
| Price to Free Cash Flow | |||||
| Enterprise Value to EBITDA |
Earnings Data
| Breakdown | 2024-12-31 |
|---|---|
| Earning YoY | |
| Revenue YoY | |
| EBITDA YoY | |
| Net Profit YoY |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Earning YoY | |||||
| Revenue YoY | 0.00 | 0.00 | |||
| EBITDA YoY | |||||
| Net Profit YoY |
Financial Strength
| Breakdown | 2024-12-31 |
|---|---|
| Cash Per Common Share | 26.58 |
| Quick Ratio | |
| Current Ratio | 6.21 |
| Debt to Equity | 0.18 |
| Long-Term Debt to Equity | 0.00 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Cash Per Common Share | 7.19 | 6.57 | 7.52 | 8.39 | 106.81 |
| Quick Ratio | |||||
| Current Ratio | 5.66 | 5.23 | 6.47 | 6.21 | 8.95 |
| Debt to Equity | 0.64 | 0.22 | 0.17 | 0.18 | 0.12 |
| Long-Term Debt to Equity | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Profitability
| Breakdown | 2024-12-31 |
|---|---|
| ROA | -42.43 |
| ROE | -50.24 |
| Gross Margin | |
| Operating Margin | -3131.18 |
| EBITDA Margin | -3128.44 |
| Net Profit Margin | -3139.76 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| ROA | -42.64 | -29.27 | -10.06 | -25.87 | |
| ROE | -69.90 | -35.80 | -11.81 | -29.04 | |
| Gross Margin | |||||
| Operating Margin | -1374.80 | -859.81 | -337.78 | ||
| EBITDA Margin | -1374.34 | -859.46 | -337.55 | ||
| Net Profit Margin | -1372.95 | -857.96 | -335.73 |
Dividends
| Breakdown | 2024-12-31 |
|---|---|
| Dividend Yield | |
| Dividend Payout Ratio |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Dividend Yield | |||||
| Dividend Payout Ratio |
Financial Statements
| Breakdown | 2024-12-31 |
|---|---|
| Assets | 369,968.00 |
| Current Assets | 355,923.00 |
| Cash and Short-Term Investments | 350,800.00 |
| Cash and Cash Equivalents | 319,832.00 |
| Short-Term Investments | 31,024.00 |
| Net Receivables | 0 |
| Inventory | 0 |
| Other Current Assets | 5,123.00 |
| Non-Current Assets | 14,045.00 |
| Property, Plant, Equipment Net | 1,189.00 |
| Goodwill | 0 |
| Intangible Assets | 0 |
| Long-Term Investments | 0 |
| Non-Current Deferred Assets | 0 |
| Other Non-Current Assets | 12,856.00 |
| Liabilities | 57,510.00 |
| Current Liabilities | 57,292.00 |
| Payables and Expenses | 58,127.00 |
| Account Payables | 18,196.00 |
| Current Accrued Liabilities | 39,931.00 |
| Short-Term Debt | 785.00 |
| Other Current Liabilities | -1,620.00 |
| Non-Current Liabilities | 218.00 |
| Long-Term Debt | 218.00 |
| Other Non-Current Liabilities | 0.00 |
| Equity | 312,458.00 |
| Shareholders Equity | 312,458.00 |
| Capital Stock | 4.00 |
| Share Premium | 699,651.00 |
| Retained Earnings | -387,391.00 |
| Treasury Shares | 0 |
| Accumulated Other Comprehensive Income | 194.00 |
| Minority Interest | 0 |
| Investments | 31,024.00 |
| Debt | 1,003.00 |
| Common Shares Outstanding | 41,793.41 |
| Breakdown | 2024-12-31 |
|---|---|
| Revenues | 5,000.00 |
| Operating Expenses | 168,888.00 |
| Selling, General and Administrative Expenses | 6,754.00 |
| Research and Development Expenses | 7,590.00 |
| Other Operating Expenses | 154,544.00 |
| Operating Income | -163,888.00 |
| Net Non-Operating Income | 7,329.00 |
| Interest Expense | 0.00 |
| EBT | -156,559.00 |
| Income Tax | 429.00 |
| Net Income | -156,988.00 |
| EBIT | -156,559.00 |
| Deprecation and Amortization | 137.00 |
| EBITDA | -156,422.00 |
| EPS | -0.01 |
| Diluted EPS | -0.01 |
| Average Shares Outstanding Basic | 13,198.96 |
| Average Shares Outstanding Diluted | 13,198.96 |
| Breakdown | 2024-12-31 |
|---|---|
| Operating Cash Flow | -119,674.00 |
| Operating Net Income | -470,964.00 |
| Deprecation and Amortization | 137.00 |
| Deferred Income Tax | 0 |
| Share Based Compensation | 10,821.00 |
| Change in Working Capital | 40,833.00 |
| Other Operating Activities | 299,499.00 |
| Investing Cash Flow | -30,552.00 |
| Capital Expenditure | 0.00 |
| Net Purchase/Sale of PPE | 131.00 |
| Net Purchase/Sale of Investments Net | 42,421.00 |
| Net Purchase/Sale of Business | 0 |
| Other Investing Activities | -73,104.00 |
| Financing Cash Flow | 412,958.00 |
| Net Issuance/Repayment of Debt | 0 |
| Net Issuance/Repurchase of Equity | 240,911.00 |
| Dividends Paid | 0 |
| Other Financing Activities | 172,047.00 |
| Net Change in Cash | 262,889.00 |
| Cash at Beginning of Period | 56,943.00 |
| Cash at End of Period | 319,832.00 |
| Free Cash Flow | 0 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Assets | 322,018.00 | 293,085.00 | 333,766.00 | 369,968.00 | 403,432.00 |
| Current Assets | 296,642.00 | 278,603.00 | 317,807.00 | 355,923.00 | 393,778.00 |
| Cash and Short-Term Investments | 301,600.00 | 274,900.00 | 314,200.00 | 350,800.00 | 386,800.00 |
| Cash and Cash Equivalents | 115,565.00 | 44,006.00 | 196,554.00 | 319,832.00 | 360,038.00 |
| Short-Term Investments | 175,319.00 | 229,273.00 | 115,825.00 | 31,024.00 | 26,761.00 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | -4,958.00 | 3,703.00 | 3,607.00 | 5,123.00 | 6,978.00 |
| Non-Current Assets | 25,376.00 | 14,482.00 | 15,959.00 | 14,045.00 | 9,654.00 |
| Property, Plant, Equipment Net | 857.00 | 1,071.00 | 1,276.00 | 1,189.00 | 545.00 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 10,717.00 | 1,614.00 | 1,835.00 | 0 | 0 |
| Non-Current Deferred Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13,802.00 | 11,797.00 | 12,848.00 | 12,856.00 | 9,109.00 |
| Liabilities | 125,590.00 | 53,459.00 | 49,449.00 | 57,510.00 | 43,997.00 |
| Current Liabilities | 52,421.00 | 53,244.00 | 49,132.00 | 57,292.00 | 43,997.00 |
| Payables and Expenses | 51,803.00 | 52,451.00 | 48,224.00 | 58,127.00 | 48,580.00 |
| Account Payables | 6,444.00 | 7,931.00 | 20,018.00 | 18,196.00 | 16,276.00 |
| Current Accrued Liabilities | 45,359.00 | 44,520.00 | 28,206.00 | 39,931.00 | 32,304.00 |
| Short-Term Debt | 618.00 | 793.00 | 908.00 | 785.00 | 384.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | -1,620.00 | -4,967.00 |
| Non-Current Liabilities | 73,169.00 | 215.00 | 317.00 | 218.00 | 0.00 |
| Long-Term Debt | 146,158.00 | 215.00 | 317.00 | 218.00 | 0 |
| Other Non-Current Liabilities | -72,989.00 | 0.00 | 0.00 | 0.00 | 0 |
| Equity | 196,428.00 | 239,626.00 | 284,317.00 | 312,458.00 | 359,435.00 |
| Shareholders Equity | 196,428.00 | 239,626.00 | 284,317.00 | 312,458.00 | 359,435.00 |
| Capital Stock | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
| Share Premium | 721,179.00 | 712,903.00 | 705,136.00 | 699,651.00 | 694,163.00 |
| Retained Earnings | -524,686.00 | -473,187.00 | -420,964.00 | -387,391.00 | -334,786.00 |
| Treasury Shares | 0 | 0 | 0 | 0 | 0 |
| Accumulated Other Comprehensive Income | -69.00 | -94.00 | 141.00 | 194.00 | 54.00 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Investments | 186,036.00 | 230,887.00 | 117,660.00 | 31,024.00 | 26,761.00 |
| Debt | 146,776.00 | 1,008.00 | 1,225.00 | 1,003.00 | 384.00 |
| Common Shares Outstanding | 42,213.46 | 42,088.70 | 41,821.89 | 41,793.41 | 41,780.94 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 10,000.00 | 10,000.00 | 10,000.00 | 0 |
| Operating Expenses | 155,073.00 | 102,493.00 | 47,330.00 | 108,265.00 |
| Selling, General and Administrative Expenses | 62,790.00 | 41,365.00 | 3,805.00 | 18,283.00 |
| Research and Development Expenses | 218,589.00 | 152,190.00 | 1,581.00 | 93,229.00 |
| Other Operating Expenses | -126,306.00 | -91,062.00 | 41,944.00 | -3,247.00 |
| Operating Income | -145,073.00 | -92,493.00 | -37,330.00 | -108,265.00 |
| Net Non-Operating Income | 7,593.00 | 6,512.00 | 3,552.00 | 3,881.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| EBT | -137,480.00 | -85,981.00 | -33,778.00 | -104,384.00 |
| Income Tax | 185.00 | 185.00 | 205.00 | 0.00 |
| Net Income | -137,295.00 | -85,796.00 | -33,573.00 | -104,384.00 |
| EBIT | -137,480.00 | -85,981.00 | -33,778.00 | -104,384.00 |
| Deprecation and Amortization | 46.00 | 35.00 | 23.00 | 104.00 |
| EBITDA | -137,434.00 | -85,946.00 | -33,755.00 | -104,280.00 |
| EPS | -0.00 | -0.00 | -0.00 | -0.03 |
| Diluted EPS | -0.00 | -0.00 | -0.00 | -0.03 |
| Average Shares Outstanding Basic | 41,943.16 | 41,833.28 | 41,800.80 | 3,621.28 |
| Average Shares Outstanding Diluted | 41,943.16 | 41,833.28 | 41,800.80 | 3,621.28 |
| Breakdown | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Operating Cash Flow | -119,919.00 | -78,794.00 | -37,051.00 | -81,120.00 |
| Operating Net Income | -137,295.00 | -85,796.00 | -100,719.00 | -104,384.00 |
| Deprecation and Amortization | 46.00 | 35.00 | 23.00 | 104.00 |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Share Based Compensation | 18,767.00 | 11,431.00 | 5,386.00 | 5,326.00 |
| Change in Working Capital | -5,766.00 | -5,304.00 | -8,152.00 | 15,615.00 |
| Other Operating Activities | 4,329.00 | 840.00 | 66,411.00 | 2,219.00 |
| Investing Cash Flow | -158,522.00 | -198,565.00 | -86,274.00 | -26,817.00 |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Purchase/Sale of PPE | 18.00 | 18.00 | 18.00 | 57.00 |
| Net Purchase/Sale of Investments Net | 416,220.00 | 252,787.00 | 111,972.00 | 26,760.00 |
| Net Purchase/Sale of Business | 0 | 0 | 0 | 0 |
| Other Investing Activities | -574,760.00 | -451,370.00 | -198,264.00 | -53,634.00 |
| Financing Cash Flow | 74,437.00 | 1,821.00 | 99.00 | 411,105.00 |
| Net Issuance/Repayment of Debt | 75,000.00 | 0 | 0 | 0 |
| Net Issuance/Repurchase of Equity | 2,761.00 | 1,821.00 | 99.00 | 234,585.00 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | -3,324.00 | 0.00 | 0.00 | 176,520.00 |
| Net Change in Cash | -204,267.00 | -275,826.00 | -123,278.00 | 303,184.00 |
| Cash at Beginning of Period | 319,832.00 | 319,832.00 | 319,832.00 | 56,943.00 |
| Cash at End of Period | 115,565.00 | 44,006.00 | 196,554.00 | 360,127.00 |
| Free Cash Flow | 0 | 0 | 0 | 0 |